top of page
Lido-Tetra 7-7 Box and Tube reverse-01.p

NDC: 69420-3077-1

Faster & Easier Pain Relief...

Lidocaine/Tetracaine 7%/7% Cream works twice as fast as EMLA and removes the need for occlusion wraps


Lidocaine/Tetracaine 7%/7% Cream is a topical prescription medicine used to provide topical local analgesia for superficial dermatological procedures such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing, and laser-assisted tattoo removal.

Active Ingredients:

Lidocaine 7%

Tetracaine 7%

Benefits of Lidocaine/Tetracaine 7%/7% Cream



Combination therapy for powerful topical pain relief: Lidocaine provides faster onset of action (within 20-30 minutes); tetracaine provides lasting effects (median duration of analgesia is 11 hours) 


Removes the need for occlusion wraps by using phase-changing topical cream peel technology: Applied as a cream that dries to a pliable membrane upon exposure to air



Used in a wide range of dermatological procedures: Including dermal filler injection, non-ablative laser facial resurfacing, pulsed-dye laser therapy, and laser-assisted tattoo removal



Limited side effects: Localized, transient skin reactions that do not appear to interfere with clinical outcome



Safe to use in geriatrics: No overall differences in safety and effectiveness were observed between 65+ year old subjects and younger subjects



High degree of stability: Can be stored at room temperature for up to 3 months


FDA-Approved For Topical Local Analgesia

Efficacy with Lidocaine/Tetracaine 7%/7% Cream

95 Percent-Icon.png



For full-face cutaneous laser resurfacing


79 Percent-Icon.png



For injection of dermal fillers for soft tissue augmentation


Mean VAS Scores-LT-Cream-min.PNG



as Fast as EMLA

Works in just 20-30 minutes vs. 1 hour



as Effective as EMLA

For cutaneous laser resurfacing



as Long as EMLA

Lasts, on average, 11 hours vs. 1-2 hours



Occlusion Wraps

Self-occluding formula means easy application


Lidocaine/Tetracaine 7%/7% Cream vs. EMLA Cream

Dosage and Administration

Using the ruler of the included applicator, squeeze out the amount of lidocaine and tetracaine cream needed for the prescribed dose. Spread the cream in an even white layer, about the thickness of a dime, over the treatment area. Leave lidocaine and tetracaine cream on the skin for the recommended time. To remove, peel the dried cream off the skin.

Contact Us

Contact Us

LidocaineTetracaine 7-7 Marketing BLUE-0

From 9am to 5pm PST, Monday to Friday

Important Safety Information


Lidocaine and tetracaine cream is contraindicated in patients with a known history of sensitivity to lidocaine or tetracaine, local anesthetics of the amide or ester type, or to any other component of the product. Lidocaine and tetracaine cream is contraindicated in patients with para-aminobenzoic acid (PABA) hypersensitivity.

Warnings and Precautions

Cases of methemoglobinemia have been reported in association with local anesthetic use. Although all patients are at risk for methemoglobinemia, patients with glucose-6-phosphate dehydrogenase deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, infants under 6 months of age, and concurrent exposure to oxidizing agents or their metabolites are more susceptible to developing clinical manifestations of the condition. If local anesthetics must be used in these patients, close monitoring for symptoms and signs of methemoglobinemia is recommended.

Patients with severe hepatic disease or pseudocholinesterase deficiency, because of their inability to metabolize local anesthetics normally, are at a greater risk of developing toxic plasma concentrations of lidocaine and tetracaine

Allergic or anaphylactic reactions have been associated with lidocaine and tetracaine and may occur with other components of lidocaine and tetracaine cream. They are characterized by urticaria, angioedema, bronchospasm, and shock. If an allergic reaction occurs, seek emergency help immediately.

Adverse Reactions

The most common local reactions were erythema, skin discoloration, and edema.

Indications and Usage

Lidocaine and tetracaine cream is a combination of lidocaine, an amide local anesthetic, and tetracaine, an ester local anesthetic, indicated for use on intact skin in adults to provide topical local analgesia for superficial dermatological procedures such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing, and laser-assisted tattoo removal.

Please also see the full Prescribing Information.


  1. Alster T. Review of lidocaine/tetracaine cream as a topical anesthetic for dermatologic laser procedures. Pain Ther. 2013;2(1):11‐19., Lidocaine/Tetracaine 7%/7% Cream [package insert]. Los Angeles, CA: SA3, LLC; 2020, EMLA (Lidocaine 2.5%/Prilocaine 2.5%) Cream [package insert]. Wayne, PA. Astra Pharmaceuticals, LP.

  2. Giordano D, Raso MG, Pernice C, Agnoletti V, Barbieri V. Topical local anesthesia: focus on lidocaine-tetracaine combination. Local Reg Anesth. 2015;8:95‐100., Lidocaine/Tetracaine 7%/7% Cream [package insert], 2020. 

  3. Alster, 2013.

  4. Lidocaine/Tetracaine 7%/7% Cream [package insert], 2020. 

  5. Alster TS. The lidocaine/tetracaine peel: a novel topical anesthetic for dermatologic procedures in adult patients. Dermatol Surg. 2007;33(9):1073‐1081

  6. Alster TS, Lupton JR. Evaluation of a novel topical anesthetic agent for cutaneous laser resurfacing: a randomized comparison study. Dermatol Surg. 2002;28(11):1004‐1006.

  7. Cohen JL, Gold MH. Evaluation of the efficacy and safety of a lidocaine and tetracaine (7%/7%) cream for induction of local dermal anesthesia for facial soft tissue augmentation with hyaluronic Acid. J Clin Aesthet Dermatol. 2014;7(10):32‐37.

  8. Lidocaine/Tetracaine 7%/7% Cream [package insert], 2020., EMLA (Lidocaine 2.5%/Prilocaine 2.5%) Cream [package insert].

About Alexso

The foundation of our success and the heart of Alexso, Inc., is our vision to provide a high range of quality pharmaceutical medications and to execute our commitment to our patients, customers, and employees.


Privately held and established in 2010, today we have a tremendous amount of growth in niche core markets. We are headquartered in Los Angles, California and are active in many states, with a future international growth strategy.


As a growing pharmaceutical company, our core strengths lie in development, production, and marketing infrastructure across the country and in relationships with many wholesale pharmaceutical distributors. We have a wide range of specialty medicines, FDA approved medication, specialized over-the-counter products, active pharmaceutical ingredients, and compounded pharmaceutical products.

Our core values are Integrity, Respect, Collaboration, Excellence and Leadership. We take pride in building and preserving long-term relationships with our suppliers and customers. By creating a supportive work environment where everyone feels engaged and connected, we take the lead in industry changes while maintaining our commitment to setting the standard in the industry. Our continuous pursuit and achievement of our mission is what makes Alexso, Inc. successful. We connect people and organizations and support the search for higher quality clinical outcomes. These core values are represented by our team and through our products with the goal of bringing safe and effective medications to the world.

bottom of page